Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
PRT4165 is a potent inhibitor of PRC1-mediated H2A ubiquitylation in vivo and in vitro
38)33(4)20-7-5-6-19(29)14-20/h5-9
InChiKey: SJVQHLPISAIATJ-ZDUSSCGKSA-N
and led to regression of orthotopic tumors
Didanosine Catalog No.:M9257-10 PRT4165 is a potent inhibitorDidanosine (2,3 dideoxyinosine, ddI, DDI) marketed under the trade names Videx and Videx EC. It is an antiretroviral medication used to treat HIV AIDS in combination with other medications as part of highly active antiretroviral therapy (HAART). It is of the reverse transcriptase inhibitor class. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system. (Source: